Details for New Drug Application (NDA): 214702
NDA 214702 describes CHLORZOXAZONE, which is a drug marketed by Actavis Elizabeth, Ajenat Pharms, Aurobindo Pharma Ltd, Barr, Chartwell Rx, Dr Reddys Labs Sa, Glenmark Pharms Ltd, Macleods Pharms, Novitium Pharma, Ohm Labs, Ph Health, Pharmazone, Pharmobedient, Pioneer Pharms, Rising, Somerset Theraps Llc, Sun Pharm Industries, Teva Pharms Usa Inc, and Watson Labs, and is included in thirty-five NDAs. It is available from nineteen suppliers. Additional details are available on the CHLORZOXAZONE profile page.
The generic ingredient in CHLORZOXAZONE is chlorzoxazone. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
The generic ingredient in CHLORZOXAZONE is chlorzoxazone. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
Summary for 214702
| Tradename: | CHLORZOXAZONE |
| Applicant: | Macleods Pharms |
| Ingredient: | chlorzoxazone |
| Patents: | 0 |
Pharmacology for NDA: 214702
| Physiological Effect | Centrally-mediated Muscle Relaxation |
Medical Subject Heading (MeSH) Categories for 214702
Suppliers and Packaging for NDA: 214702
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 214702 | ANDA | Camber Pharmaceuticals, Inc. | 31722-974 | 31722-974-01 | 100 TABLET in 1 BOTTLE (31722-974-01) |
| CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 214702 | ANDA | Camber Pharmaceuticals, Inc. | 31722-974 | 31722-974-05 | 500 TABLET in 1 BOTTLE (31722-974-05) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
| Approval Date: | Apr 10, 2023 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
